Nephros Inc (NEPH)
2.09
-0.01
(-0.48%)
USD |
NASDAQ |
Apr 22, 16:00
2.08
-0.01
(-0.48%)
After-Hours: 20:00
Nephros Gross Profit (Quarterly): 2.021M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.021M |
September 30, 2023 | 2.194M |
June 30, 2023 | 2.079M |
March 31, 2023 | 2.111M |
December 31, 2022 | 1.509M |
September 30, 2022 | 0.762M |
June 30, 2022 | 1.395M |
March 31, 2022 | 1.053M |
December 31, 2021 | 1.471M |
September 30, 2021 | 1.36M |
June 30, 2021 | 1.275M |
March 31, 2021 | 1.587M |
December 31, 2020 | 1.302M |
September 30, 2020 | 1.225M |
June 30, 2020 | 0.895M |
March 31, 2020 | 1.491M |
December 31, 2019 | 1.90M |
September 30, 2019 | 1.819M |
June 30, 2019 | 1.367M |
March 31, 2019 | 0.998M |
December 31, 2018 | 0.954M |
September 30, 2018 | 0.952M |
June 30, 2018 | 0.83M |
March 31, 2018 | 0.467M |
December 31, 2017 | 0.788M |
Date | Value |
---|---|
September 30, 2017 | 0.532M |
June 30, 2017 | 0.517M |
March 31, 2017 | 0.455M |
December 31, 2016 | 0.386M |
September 30, 2016 | 0.316M |
June 30, 2016 | 0.297M |
March 31, 2016 | 0.295M |
December 31, 2015 | 0.253M |
September 30, 2015 | 0.166M |
June 30, 2015 | 0.358M |
March 31, 2015 | 0.282M |
December 31, 2014 | 0.216M |
September 30, 2014 | 0.316M |
June 30, 2014 | 0.299M |
March 31, 2014 | 0.367M |
December 31, 2013 | -0.062M |
September 30, 2013 | 0.229M |
June 30, 2013 | 0.349M |
March 31, 2013 | 0.325M |
December 31, 2012 | 0.079M |
September 30, 2012 | 0.413M |
June 30, 2012 | 0.267M |
March 31, 2012 | 0.311M |
December 31, 2011 | 0.157M |
September 30, 2011 | 0.309M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.762M
Minimum
Sep 2022
2.194M
Maximum
Sep 2023
1.517M
Average
1.471M
Median
Dec 2021
Gross Profit (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 1.541M |
Xtant Medical Holdings Inc | 17.14M |
Asensus Surgical Inc | 1.166M |
Catheter Precision Inc | 0.121M |